Alex Nivorozhkin
Direttore Tecnico/Scientifico/R&S presso CYBIN INC.
Patrimonio netto: 1 M $ in data 30/06/2024
Posizioni attive di Alex Nivorozhkin
Società | Posizione | Inizio | Fine |
---|---|---|---|
CYBIN INC. | Direttore Tecnico/Scientifico/R&S | 01/12/2020 | - |
Adelia Therapeutics, Inc.
Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adelia Therapeutics, Inc. operates as an biopharmaceutical company. The company was founded by Alex Nivorozhkin and Brett J. Greene in 2020 and is headquartered in Fitchburg, MA. | Direttore/Membro del Consiglio | 01/01/2020 | - |
Amministratore Delegato | 01/01/2020 | - | |
Fondatore | 01/01/2020 | - | |
Amorsa Therapeutics, Inc.
Amorsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Amorsa Therapeutics, Inc. is an American neuron pharmaceutical company. The company is based in Southborough. | Direttore operativo | - | - |
International Cannabinoid Research Society | Corporate Officer/Principal | - | - |
Storia della carriera di Alex Nivorozhkin
Precedenti posizioni note di Alex Nivorozhkin
Società | Posizione | Inizio | Fine |
---|---|---|---|
Center For Integration of Medicine & Innovative Technology | Corporate Officer/Principal | - | - |
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | Corporate Officer/Principal | - | - |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Corporate Officer/Principal | - | - |
Neo-Advent Technologies LLC | Corporate Officer/Principal | - | - |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Corporate Officer/Principal | - | - |
░░░░░░ ░░░░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Formazione di Alex Nivorozhkin
Rostov State University | Doctorate Degree |
Statistiche
Distribuzione geografica
Stati Uniti | 10 |
Canada | 2 |
Russia | 2 |
Posizioni
Corporate Officer/Principal | 7 |
Director/Board Member | 1 |
Chief Executive Officer | 1 |
Settori
Health Technology | 7 |
Consumer Services | 2 |
Health Services | 2 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
Società quotate in Borsa | 1 |
---|---|
CYBIN INC. | Health Technology |
Aziende private | 9 |
---|---|
Adelia Therapeutics, Inc.
Adelia Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Adelia Therapeutics, Inc. operates as an biopharmaceutical company. The company was founded by Alex Nivorozhkin and Brett J. Greene in 2020 and is headquartered in Fitchburg, MA. | Health Technology |
Amorsa Therapeutics, Inc.
Amorsa Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Amorsa Therapeutics, Inc. is an American neuron pharmaceutical company. The company is based in Southborough. | Health Technology |
Boston BioCom LLC
Boston BioCom LLC Pharmaceuticals: MajorHealth Technology Boston BioCom LLC develops and commercializes life science technologies. The company was founded by Alexey V. Eliseev in 2007 is headquartered in Boston, MA. | Health Technology |
International Cannabinoid Research Society | |
The General Hospital Corp.
The General Hospital Corp. Hospital/Nursing ManagementHealth Services The General Hospital Corp. provides healthcare services. It offers diagnostic and therapeutic are in every specialty and subspecialty of medicine and surgery. The firm's care center provides cancer, digestive disorders, heart disease, transplantation and vascular medicine services. The company was founded in 1811 and is headquartered in Boston, MA. | Health Services |
Neo-Advent Technologies LLC | |
EPIX Pharmaceuticals, Inc.
EPIX Pharmaceuticals, Inc. Medical SpecialtiesHealth Technology EPIX Pharmaceuticals, Inc. used to develop targeted contrast agents both to improve the capability and expand the use of magnetic resonance imaging (MRI) as a tool for diagnosing human disease. The company was founded in 1988 and was headquartered in Lexington, MA. | Health Technology |
Inotek Pharmaceuticals Corp.
Inotek Pharmaceuticals Corp. Pharmaceuticals: MajorHealth Technology Inotek Pharmaceuticals Corp. is a clinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of therapies for glaucoma and other diseases of the eye. The company's product candidate includes Trabodenoson, an adenosine mimetic that has completed Phase II clinical trials for lowering IOP by restoring the eye's natural pressure control mechanism. It is also developing Trabodenoson plus Latanoprost, a prostaglandin analogue that has completed Phase II clinical trials for use in patients with inadequate responses to treatment with latanoprost; and Trabodenoson monotherapy for the treatment of optic nerve neuropathy. Inotek Pharmaceuticals was founded on July 7, 1999 by Csaba Szabo and Andrew L. Salzman and is headquartered in Lexington, MA. | Health Technology |
Center For Integration of Medicine & Innovative Technology |
- Borsa valori
- Insiders
- Alex Nivorozhkin
- Esperienza